Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX TrialLeif Bjermer, Isabelle H Boucot, François Maltais, et al.American Journal of Respiratory and Critical Care Medicine|June 14, 2023
Use of CAPTURE to Identify Individuals Who May or May Not Require Treatment for Chronic Obstructive Pulmonary DiseaseYun Li, Fuqiang Wen, Qianli Ma, et al.International Journal of Chronic Obstructive Pulmonary Disease|May 12, 2021
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important ImprovementClaus F Vogelmeier, Ian P Naya, François Maltais, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPDJean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.ERJ Open Research|June 17, 2025
Unmet needs of patients with COPD in Germany: a retrospective, cross-sectional studyFelix J F Herth, Claus F Vogelmeier, Franziska C Trudzinski, et al.Chronic Respiratory Disease|October 6, 2023
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?Edward M Kerwin, Paul W Jones, Leif H Bjermer, et al.Respiratory Medicine|July 8, 2022
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPDFrançois Maltais, Claus F Vogelmeier, Edward M Kerwin, et al.ERJ Open Research|February 11, 2026
Predictors of COPD exacerbations differ between grades of airflow limitationYi Lan, Rongchang Chen, Jinping Zheng, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 25, 2021
A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study DesignNobuyuki Hizawa, Koichi Fukunaga, Hisatoshi Sugiura, et al.Therapeutic Advances in Respiratory Disease|November 10, 2020
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trialClaus F Vogelmeier, Edward M Kerwin, Leif H Bjermer, et al.Pageof 8